(19)
(11) EP 3 650 444 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
18.10.2023 Bulletin 2023/42

(45) Mention of the grant of the patent:
07.09.2022 Bulletin 2022/36

(21) Application number: 18827841.0

(22) Date of filing: 02.07.2018
(51) International Patent Classification (IPC): 
C07D 239/32(2006.01)
A61P 15/10(2006.01)
 C07D 239/36(2006.01)
A61K 31/506(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 15/10; C07D 239/36
(86) International application number:
PCT/CN2018/093965
(87) International publication number:
WO 2019/007299 (10.01.2019 Gazette 2019/02)

(54)

SALT AND POLYMORPH OF BENZOPYRIMIDINONE COMPOUND AND PHARMACEUTICAL COMPOSITION AND USE THEREOF

SALZ UND POLYMORPH EINER BENZOPYRIMIDINONVERBINDUNG UND PHARMAZEUTISCHE ZUSAMMENSETZUNG UND VERWENDUNG DAVON

SEL ET POLYMORPHE DE COMPOSÉ BENZOPYRIMIDINONE, COMPOSITION PHARMACEUTIQUE ET UTILISATION ASSOCIÉE

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 07.07.2017 CN 201710551480

(43) Date of publication of application:
13.05.2020 Bulletin 2020/20

(73) Proprietors:
  • Shanghai Institute of Materia Medica, Chinese Academy of Sciences
    Pudong, Shanghai 201203 (CN)
  • Vigonvita Life Sciences Co., Ltd.
    Suzhou, Jiangsu 215123 (CN)

(72) Inventors:
  • SHEN, Jingshan
    Pudong Shanghai 201203 (CN)
  • HE, Yang
    Pudong Shanghai 201203 (CN)
  • CHEN, Weiming
    Pudong Shanghai 201203 (CN)
  • LI, Jianfeng
    Pudong Shanghai 201203 (CN)
  • TIAN, Guanghui
    Suzhou Jiangsu 215123 (CN)
  • GONG, Xudong
    Pudong Shanghai 201203 (CN)
  • WANG, Zhen
    Pudong Shanghai 201203 (CN)
  • ZHANG, Rongxia
    Pudong Shanghai 201203 (CN)
  • LIU, Yongjian
    Pudong Shanghai 201203 (CN)
  • JIANG, Hualiang
    Pudong Shanghai 201203 (CN)

(74) Representative: Petraz, Gilberto Luigi et al
GLP S.r.l.
Viale Europa Unita, 171 33100 Udine
Viale Europa Unita, 171 33100 Udine (IT)


(56) References cited: : 
EP-A1- 0 636 626
WO-A1-2010/066111
 WO-A1-2009/106531
CN-A- 1 746 171
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).